Global Peptide Therapeutics Market By Type (Generic Peptide Therapeutics, and Branded Peptide Therapeutics), By Application (Cancer, Cardiovascular, Central Nervous System, and others), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029
- 137131
- 18-Dec
- PDF/PPT/Word
-
Report Details
The report on Peptide Therapeutics Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global peptide therapeutics market is segmented on the basis of Type, Application, and geography.
The global Peptide Therapeutics market was valued at US$ XX.X Mn in 2018 and is projected to increase significantly at a CAGR of x.x% from 2019 to 2028.
Peptide Therapeutics Market Scope:
By type, the market is segmented into Generic Peptide Therapeutics, and Branded Peptide Therapeutics. By Application, the market is divided into Cancer, Cardiovascular, Central Nervous System, Metabolic Disorders, Infection, and Hematological Disorders.
Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Amgen, Roche, Takeda Pharmaceutical, Lonza, Novartis, AstraZeneca, Bachem, CordenPharma, Eli Lilly, Sanofi, Ipsen, Merck, Novo Nordisk, PolyPeptide Group, and Teva.Key Market Segments
Type
Generic Peptide Therapeutics
Branded Peptide TherapeuticsApplication
Cancer
Cardiovascular
Central Nervous System
Metabolic Disorders
Infection
Hematological DisordersKey Market Players included in the report:
Amgen
Roche
Takeda Pharmaceutical
Lonza
Novartis
AstraZeneca
Bachem
CordenPharma
Eli Lilly
Sanofi
Ipsen
Merck
Novo Nordisk
PolyPeptide Group
TevaReasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis industry research (global industry trends) and Peptide Therapeutics Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Peptide Therapeutics Market; high-growth regions; and market drivers, restraints, and also market chances.
The analysis covers Peptide Therapeutics Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Peptide Therapeutics Market across sections such as also Application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Peptide Therapeutics Market together side their company profiles, SWOT analysis, latest advancements, and business plans.The analysis objectives of the report are:
To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
To know the Peptide Therapeutics Market by pinpointing its many subsegments.
To profile the important players and analyze their growth plans.
To endeavor the amount and value of Peptide Therapeutics sub-markets, depending on key regions (various vital states).
To analyze Peptide Therapeutics Market concerning growth trends, prospects, and also their participation in the entire sector.
To examine and study the Peptide Therapeutics Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2012 to 2018, and also prediction to 2028.
Primary worldwide Peptide Therapeutics Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market. -
Table Of Content
1. Peptide Therapeutics Market Introduction
1.1. Definition
1.2. Taxonomy
1.3. Research Scope2. Executive Summary2.1. Key Findings by Major Segments
2.2. Top strategies by Major Players3. Global Peptide Therapeutics Market Overview3.1. Peptide Therapeutics Market Dynamics
3.1.1. Drivers
3.1.2. Opportunities
3.1.3. Restraints
3.1.4. Challenges3.2. PESTLE Analysis
3.3. Opportunity Map Analysis
3.4. PORTER’S Five Forces Analysis
3.5. Market Competition Scenario Analysis
3.6. Product Life Cycle Analysis
3.7. Opportunity Orbits
3.8. Manufacturer Intensity Map4. Global Peptide Therapeutics Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Type, 2012-20284.1. Global Peptide Therapeutics Market Analysis by Type: Introduction
4.2. Market Size and Forecast by Region
4.3. Generic Peptide Therapeutics
4.4. Branded Peptide Therapeutics5. Global Peptide Therapeutics Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Application, 2012-20285.1. Global Peptide Therapeutics Market Analysis by Application: Introduction
5.2. Market Size and Forecast by Region
5.3. Cancer
5.4. Cardiovascular
5.5. Central Nervous System
5.6. Metabolic Disorders
5.7. Infection
5.8. Hematological Disorders6. Global Peptide Therapeutics Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Region, 2012-20286.1. North America
6.1.1. North America Peptide Therapeutics Market: Regional Trend Analysis
6.1.1.1. US
6.1.1.2. Canada
6.1.1.3. Mexico6.2.1. Europe
6.2.1. Europe Peptide Therapeutics Market: Regional Trend Analysis
6.2.1.1. Germany
6.2.1.2. France
6.2.1.3. UK
6.2.1.4. Russia
6.2.1.5. Italy
6.2.1.6. Rest of Europe6.3. Asia-Pacific
6.3.1. Asia-Pacific Peptide Therapeutics Market: Regional Trend Analysis
6.3.1.1. China
6.3.1.2. Japan
6.3.1.3. Korea
6.3.1.4. India
6.3.1.5. Rest of Asia6.4. Latin America
6.4.1. Latin America Peptide Therapeutics Market: Regional Trend Analysis
6.4.1.1. Brazil
6.4.1.2. Argentina
6.4.1.3. Rest of Latin America6.5. Middle East and Africa
6.5.1. Middle East and Africa Peptide Therapeutics Market: Regional Trend Analysis
6.5.1.1. GCC
6.5.1.2. South Africa
6.5.1.3. Israel
6.5.1.4. Rest of MEA
7. Global Peptide Therapeutics Market Competitive Landscape, Market Share Analysis, and Company Profiles7.1. Market Share Analysis
7.2. Company Profiles
7.3. Amgen7.3.1. Company Overview
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. SWOT Analysis
7.3.5. Key Strategies and Developments7.4. Roche7.4.1. Company Overview
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. SWOT Analysis
7.4.5. Key Strategies and Developments7.5. Takeda Pharmaceutical7.5.1. Company Overview
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. SWOT Analysis
7.5.5. Key Strategies and Developments7.6. Lonza7.6.1. Company Overview
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. SWOT Analysis
7.6.5. Key Strategies and Developments7.7. Novartis7.7.1. Company Overview
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. SWOT Analysis
7.7.5. Key Strategies and Developments7.8. AstraZeneca7.8.1. Company Overview
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. SWOT Analysis
7.8.5. Key Strategies and Developments7.9. Bachem7.9.1. Company Overview
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. SWOT Analysis
7.9.5. Key Strategies and Developments7.10. CordenPharma7.10.1. Company Overview
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. SWOT Analysis
7.10.5. Key Strategies and Developments7.11. Eli Lilly7.11.1. Company Overview
7.11.2. Financial Highlights
7.11.3. Product Portfolio
7.11.4. SWOT Analysis
7.11.5. Key Strategies and Developments7.12. Sanofi7.12.1. Company Overview
7.12.2. Financial Highlights
7.12.3. Product Portfolio
7.12.4. SWOT Analysis
7.12.5. Key Strategies and Developments7.13. Ipsen7.13.1. Company Overview
7.13.2. Financial Highlights
7.13.3. Product Portfolio
7.13.4. SWOT Analysis
7.13.5. Key Strategies and Developments7.14. Merck7.14.1. Company Overview
7.14.2. Financial Highlights
7.14.3. Product Portfolio
7.14.4. SWOT Analysis
7.14.5. Key Strategies and Developments7.15. Novo Nordisk7.15.1. Company Overview
7.15.2. Financial Highlights
7.15.3. Product Portfolio
7.15.4. SWOT Analysis
7.15.5. Key Strategies and Developments7.16. PolyPeptide Group7.16.1. Company Overview
7.16.2. Financial Highlights
7.16.3. Product Portfolio
7.16.4. SWOT Analysis
7.16.5. Key Strategies and Developments7.17. Teva7.17.1. Company Overview
7.17.2. Financial Highlights
7.17.3. Product Portfolio
7.17.4. SWOT Analysis
7.17.5. Key Strategies and Developments8. Assumptions and Acronyms
9. Research Methodology
10. Contact -
Inquiry Before Buying
-
Request Sample
